Clinical Trial Update: Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of dasatinib and vorinostat in patients with accelerated or blast phase chronic myeloid leukemia or acute lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)
• Zolinza (vorinostat)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED